TABILIO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 2.948
EU - Europa 2.226
AS - Asia 1.937
SA - Sud America 305
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 7.476
Nazione #
US - Stati Uniti d'America 2.897
SG - Singapore 881
UA - Ucraina 454
IE - Irlanda 341
SE - Svezia 333
CN - Cina 278
RU - Federazione Russa 262
BR - Brasile 236
VN - Vietnam 225
HK - Hong Kong 213
DE - Germania 202
IT - Italia 157
FI - Finlandia 151
GB - Regno Unito 115
FR - Francia 110
KR - Corea 101
TR - Turchia 45
IN - India 42
BD - Bangladesh 32
AR - Argentina 26
CA - Canada 22
JP - Giappone 18
IQ - Iraq 17
MX - Messico 17
UZ - Uzbekistan 17
AT - Austria 15
ZA - Sudafrica 15
CH - Svizzera 12
BE - Belgio 10
CO - Colombia 10
CZ - Repubblica Ceca 10
MA - Marocco 10
PK - Pakistan 10
PL - Polonia 10
EC - Ecuador 9
NL - Olanda 9
CL - Cile 8
GR - Grecia 8
AZ - Azerbaigian 7
LB - Libano 7
PY - Paraguay 7
SA - Arabia Saudita 7
ES - Italia 6
ID - Indonesia 6
RO - Romania 6
TN - Tunisia 6
VE - Venezuela 6
EG - Egitto 5
ET - Etiopia 5
OM - Oman 5
PH - Filippine 5
JO - Giordania 4
KE - Kenya 4
LT - Lituania 4
AU - Australia 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
MY - Malesia 3
TT - Trinidad e Tobago 3
AL - Albania 2
JM - Giamaica 2
PS - Palestinian Territory 2
QA - Qatar 2
AE - Emirati Arabi Uniti 1
BF - Burkina Faso 1
BG - Bulgaria 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
NP - Nepal 1
NR - Nauru 1
PT - Portogallo 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 7.476
Città #
Singapore 626
Chandler 427
Dublin 341
San Jose 252
Jacksonville 247
San Mateo 243
Hong Kong 213
Ashburn 183
Boardman 132
Dong Ket 115
Seoul 101
Santa Clara 94
Beijing 83
Medford 79
Princeton 78
Ann Arbor 77
Moscow 72
Lauterbourg 66
Wilmington 63
Andover 59
Los Angeles 51
Helsinki 49
Munich 40
Piscataway 40
New York 39
Altamura 33
Shanghai 33
Ho Chi Minh City 32
Lawrence 32
Woodbridge 29
Perugia 25
Izmir 23
Hanoi 21
Houston 21
Saint Petersburg 21
Turku 21
Norwalk 18
The Dalles 17
Tokyo 17
Auburn Hills 16
Des Moines 16
São Paulo 15
Orem 14
Falkenstein 13
Dallas 12
Johannesburg 12
Brooklyn 11
Council Bluffs 11
Brussels 10
Foligno 10
Redwood City 10
Chennai 9
Denver 9
London 9
Rio de Janeiro 9
Tashkent 9
Phoenix 8
San Paolo di Civitate 8
Ankara 7
Baku 7
Brno 7
Charlotte 7
Chicago 7
Falls Church 7
Frankfurt am Main 7
Philadelphia 7
Baghdad 6
Dhaka 6
Haiphong 6
Lahore 6
New Delhi 6
Toronto 6
Addis Ababa 5
Belo Horizonte 5
Bexley 5
Boston 5
Brasília 5
Curitiba 5
Da Nang 5
Dearborn 5
Mexico City 5
Milan 5
Montreal 5
Rome 5
San Francisco 5
Warsaw 5
Amsterdam 4
Asunción 4
Barnet 4
Memphis 4
Ottawa 4
Piediluco 4
Quito 4
Ribeirão Preto 4
Roubaix 4
Stockholm 4
Tunis 4
Atlanta 3
Bogotá 3
Bologna 3
Totale 4.539
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 187
Sovraccarico di ferro in pazienti affetti da linfoma non Hodgkin (LNH) sottoposti a trapianto di midollo osseo autologo (A-TMO) ed emocromatosi ereditaria: esiste correlazione? Atti del IX Congresso Nazionale S.I.G.U. 183
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 172
B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha. 167
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 154
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 144
Apoptosis of human primary B lymphocytes is inhibited by N-acetyl-L-cysteine 141
Graft engineering for allogeneic haploidentical stem cell transplantation 135
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. 134
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 130
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 129
Fourth international workshop on haploidentical transplants, Naples, Italy 126
Mesenchymal cells: a vehicle for gene therapy 125
Modulating the gene silencing: novel insights to overcame gene therapy major limitation also in orthopaedic applications. 122
Recruitment of beta-hexosaminidase activity on plasma membrane and human T-cell activation-52° Congresso SIB 121
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 121
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 120
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 118
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 117
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 117
Characterization of a Unique Cd133+ Leukemia Cell Line Responsive to FGF2 and TGFb1 113
Plasma membrane associated beta-hexosaminidase activity increases during human T-cells activation 112
Decreased bone mineral density after autologous stem cell transplantation. 109
Histone deacetylation in retroviral driven transgene silencing: role of TSA as a pharmacological support for gene therapy 106
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 106
New perspectives in haematopoietic stem cell transplantation. Transplantation across HLA barriers. 105
Allogeneic transplantation across the HLA barriers. 105
Transplants across human leukocyte antigen barriers 104
Characterization of human lysosomal α-D-mannosidase in leukaemic and non leukaemic cells 104
Characterization of a unique CD133+leukemia cell line responsive to FGF2 and TGFbeta1 103
. Mismatched hematopoietic stem cell transplants in elderly patients. 103
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 102
Raccolta dei progenitori emopoietici circolanti allogenici con separatore cellulare a flusso discontinuo. . 101
Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation 100
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells 100
Stem cell mobilization in normal donors. 95
Haploidentical stem cell transplantation for acute leukemia 93
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 93
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 92
Mismatched hematopoietic stem cell transplantation in secondary leukemia 91
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 91
A mature thymocyte-like phenotypic pattern on human cord circulating T-lymphoid cells. 91
High efficient gene transfer transduction using herpes simplex virus thymidine kinase (HSV-TK) gene: a comparison of different infection protocols. 88
Unique human CD133+ leukemia cell line and its modulation towards a mesenchymal phenotype by FGF2 and TGFbeta1 87
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production. 86
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 85
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 84
Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. 84
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 83
Mesenchymal cells recruit and regulate T regulatory cells. 83
Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation. 81
Full haplotype mismatched transplant in high risk acute leukemia patients. 80
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation. 80
IL-7 engineered donor stromal cells in vitro: a new approach for hastening naive T cell recruitment. 79
Diagnostic considerations on visceral leishmaniasis. Two case reports 79
Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion based mechanism mediated by TNF-{alpha} 78
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 78
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 78
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 77
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 76
Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. 76
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 74
HSV-TK gene as a potential tool for gene generating a controlled graft-versus-host/graft-versus-leukemia effect 74
Implicazione della deacetilazione degli istoni nel silenziamento di transgeni veicolati tramite vettori retrovirali: ipotetico ruolo del TSA come supporto della terapia genica. 73
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 73
High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase. 70
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection. 67
Primary eyelid plasmacytoma. 65
In vivo demethylation of a MoMuLV retroviral vector expressing the herpes simplex thymidine kinase suicide gene by 5' azacytidine. 65
Eradication of B-CLL by Autologous and Allogeneic Host Non-Reactive Anti-Third Party CTLs. 64
The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients. 63
Haematopoietic and Stromal Stem Cell Regulation by Extracellular Matrix Components and Growth Factors 59
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 59
Homing and survival of thymidine kinase transduced T-limphocytes into NOD/SCID mice. 56
Homing and survival of thimidine kinase transduced human T-cells in NOD/SCID mice. 55
Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patients. 54
Haploidentical stem cell transplantation in leukemia 54
Interleukin 7 retroviral gene transfer in human stromal cells enhances the survival of naive T lymphocyte. . 52
Totale 7.601
Categoria #
all - tutte 30.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.491


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 0 0 129
2021/2022774 18 196 32 71 33 6 10 217 3 7 94 87
2022/20231.200 87 161 3 122 98 141 0 60 476 3 30 19
2023/2024443 27 47 30 4 1 9 101 24 56 13 46 85
2024/20251.079 24 118 26 56 183 25 21 78 193 71 184 100
2025/20262.305 172 163 124 304 299 235 410 111 240 192 36 19
Totale 7.601